Delivery Order SPE2DB20D3303-SPE2DB24FA1PB

Award Date 7/30/24
Potential Completion Date 8/20/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,242.15 firm fixed-price delivery order is for the supply of BRUKINSA 80 MG CAPSULE 120S, with an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a $7,242.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a prescription medication, to support federal healthcare programs. The contract has an ultimate completion date of September 3, 2024 and was awarded on August 12, 2024. This contract is not set aside for any specific business type....
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $36,210.75 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,565,087,149 units of the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S. This order was placed under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This is a $6,370.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a medical product, with a period of performance through April 8, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a medication, with a ceiling value of $12,740.00. The contract is a firm fixed-price, non-set-aside contract with a period of performance through July 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a $6,370.00 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, to support federal healthcare programs. The contract has a total ceiling value of $6,370.00 and runs through March 20, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $7,242.15 firm fixed price contract is for the supply of 4,565,585,855 units of the prescription drug BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,861 units of the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S. The contract has a ceiling value of $7,242.15 and an ultimate completion date of July 2, 2024. The contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), which is a major acquisition and logistics agency supporting the U.S. Department of Defense. Amerisourcebergen, a large...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $7,242.15 to provide BRUKINSA 80 MG CAPSULE 120S medication. The contract has a period of performance through April 29, 2024. This delivery order is a child contract under an indefinite delivery contract (IDC) issued by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.00 firm fixed price contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, with a completion date of June 3, 2025. This is a non-set-aside delivery order contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA1PB
    Delivery Order

This is a $7,242.15 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a period of performance through August 2024. The contract is a firm-fixed-price type with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. government, including military treatment facilities and veterans' healthcare programs. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a comprehensive range of medical commodities to support government healthcare needs.

Generated 10/29/24, 9:19 AM